» Articles » PMID: 38435826

AI-organoid Integrated Systems for Biomedical Studies and Applications

Overview
Date 2024 Mar 4
PMID 38435826
Authors
Affiliations
Soon will be listed here.
Abstract

In this review, we explore the growing role of artificial intelligence (AI) in advancing the biomedical applications of human pluripotent stem cell (hPSC)-derived organoids. Stem cell-derived organoids, these miniature organ replicas, have become essential tools for disease modeling, drug discovery, and regenerative medicine. However, analyzing the vast and intricate datasets generated from these organoids can be inefficient and error-prone. AI techniques offer a promising solution to efficiently extract insights and make predictions from diverse data types generated from microscopy images, transcriptomics, metabolomics, and proteomics. This review offers a brief overview of organoid characterization and fundamental concepts in AI while focusing on a comprehensive exploration of AI applications in organoid-based disease modeling and drug evaluation. It provides insights into the future possibilities of AI in enhancing the quality control of organoid fabrication, label-free organoid recognition, and three-dimensional image reconstruction of complex organoid structures. This review presents the challenges and potential solutions in AI-organoid integration, focusing on the establishment of reliable AI model decision-making processes and the standardization of organoid research.

Citing Articles

Revolutionising oral organoids with artificial intelligence.

Yang J, Fischer N, Ye Z Biomater Transl. 2025; 5(4):372-389.

PMID: 39872928 PMC: 11764189. DOI: 10.12336/biomatertransl.2024.04.004.


Organoids in skin wound healing.

Wang Z, Zhao F, Lang H, Ren H, Zhang Q, Huang X Burns Trauma. 2025; 13:tkae077.

PMID: 39759541 PMC: 11697111. DOI: 10.1093/burnst/tkae077.


Standardization and consensus in the development and application of bone organoids.

Wang J, Chen X, Li R, Wang S, Geng Z, Shi Z Theranostics. 2025; 15(2):682-706.

PMID: 39744680 PMC: 11671374. DOI: 10.7150/thno.105840.


Advancing cancer research through organoid technology.

Zeng G, Yu Y, Wang M, Liu J, He G, Yu S J Transl Med. 2024; 22(1):1007.

PMID: 39516934 PMC: 11545094. DOI: 10.1186/s12967-024-05824-1.


Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine.

Yao Q, Cheng S, Pan Q, Yu J, Cao G, Li L MedComm (2020). 2024; 5(10):e735.

PMID: 39309690 PMC: 11416091. DOI: 10.1002/mco2.735.


References
1.
Gupta H, Jin K, Nguyen H, McCann M, Unser M . CNN-Based Projected Gradient Descent for Consistent CT Image Reconstruction. IEEE Trans Med Imaging. 2018; 37(6):1440-1453. DOI: 10.1109/TMI.2018.2832656. View

2.
Zhang Z, Xu Z, Yuan F, Jin K, Xiang M . Retinal Organoid Technology: Where Are We Now?. Int J Mol Sci. 2021; 22(19). PMC: 8549701. DOI: 10.3390/ijms221910244. View

3.
Kelchtermans P, Bittremieux W, De Grave K, Degroeve S, Ramon J, Laukens K . Machine learning applications in proteomics research: how the past can boost the future. Proteomics. 2013; 14(4-5):353-66. DOI: 10.1002/pmic.201300289. View

4.
Gritti N, Lim J, Anlas K, Pandya M, Aalderink G, Martinez-Ara G . MOrgAna: accessible quantitative analysis of organoids with machine learning. Development. 2021; 148(18). PMC: 8451065. DOI: 10.1242/dev.199611. View

5.
Boutros M, Heigwer F, Laufer C . Microscopy-Based High-Content Screening. Cell. 2015; 163(6):1314-25. DOI: 10.1016/j.cell.2015.11.007. View